Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Sarcopenia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... 51 million cases of sarcopenia in the 16 countries covered in GlobalData’s epidemiology forecast for sarcopenia. There is no FDA approved marketed product for the treatment of sarcopenia. The sarcopenia pipeline consists of 41 pharmaceuticals ... Read More
-
Vulvovaginal Candidiasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Vulvovaginal Candidiasis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Triple-Negative Breast Cancer (TNBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Triple-Negative Breast Cancer (TNBC) Clinical trials scenario. This report provides top line data ... Read More
-
Marfan Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Marfan Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Cervical Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)
... USD 289.64 billion by 2027, registering a CAGR of 7.29% during the forecast period. Key Highlights As a result of the rising demand for generic medicines and biologics, the capital-intensive nature of the business, and ... Read More
-
Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Diabetic Foot Ulcers Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Frost Radar™: North American Clinical Documentation Improvement Market, 2022
... revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient’s care, facilitates accurate reimbursement, and ensures compliance risk management and revenue ... Read More
-
Europe Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Phase (Phase I, Phase II, Phase III, Phase IV), By Region, And Segment Forecasts, 2022 - 2030
... Europe Clinical Trials Market Growth & Trends The Europe clinical trials market size is expected to reach USD 20.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is ... Read More
-
Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Lab, Consulting), Therapeutic Area (Oncology, Infectious Disease, Neurology, Immunology, Hematology, Vaccines), End User - Global Forecast to 2027
... estimated to grow at a CAGR of 11.0% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment in pharmaceutical R&D, rising number of ... Read More
-
Sarcoidosis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021 Update
... the pipeline with 95% molecules present in early-to-mid stage. Large to mid-sized Pharma dominates clinical development in this space. Approval and launch of late-stage pipeline therapies are expected to drive the market. However, the market ... Read More
-
Philippines Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
... Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies the key trends in the country’s healthcare market and provides insights ... Read More
-
eClinical solutions Market Size By Solution (Randomization and Trial Supply Management (RTSM), Clinical Data Management System (CDMS), Clinical Trial Management System (CTMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master Files (ETMF), Electronic Data Capture (EDC)), By Delivery Mode (Licensed Enterprise (On-premise) solutions, Cloud-based (SAAS) solutions, Web-hosted (On-demand) solutions), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Contract Research Organizations (CROs), Medical Device Companies, Pharma/Biotech Companies, Hospitals & Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
... (EDC)), By Delivery Mode (Licensed Enterprise (On-premise) solutions, Cloud-based (SAAS) solutions, Web-hosted (On-demand) solutions), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Contract Research Organizations (CROs), Medical Device Companies, ... Read More
-
2022 Global: Electronic Trial Master File (Etmf) Systems - Innovative Markets Forecast (2028) report
... and regional data for the period 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
Global Pharmaceuticals Outlook, 2022
... mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-being and delaying endemicity. The ongoing pandemic has accelerated pharma and biotech companies' transformation, and clinical trial decentralization, ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022
... interventions to curb these potential disasters. The COVID-19 Clinical and Commercial Analyzer is an interactive Excel-based tool that scores leading pipeline-stage vaccines and therapeutics on a range of clinical and commercial parameters based on available ... Read More
-
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
... ganglioside GD2 is a major focus of drug developers. There are 131 drugs in the pipeline with 98% molecules present in early-to-mid stage. Mid-sized Pharma dominates clinical development in this space. More frequent use of ... Read More
-
Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026
... 90% molecules present in early stage. Mid-sized Pharma dominates R&D in this indication. The rising prevalence and more frequent use of newer symptomatic treatments are expected to drive the market. However, the market growth is ... Read More
-
Clinical Trial Management System (CTMS) Market Forecasts to 2028 – Global Analysis By Component (Hardware, Software, Services), Application (Patient Management Solutions, Data Management Solutions) and By Geography
... Management System (CTMS) Market is accounted for $918.75 million in 2021 and is expected to reach $2,708.27 million by 2028 growing at a CAGR of 16.7% during the forecast period. Clinical Trial Management System (CTMS) ... Read More
-
Global eClinical Solutions Growth Opportunities
... uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 and 3 clinical trials. The total number of open trials (recruiting, enrolling by invitations) in 2021 went ... Read More
-
Bronchopulmonary Dysplasia - Market Insight, Epidemiology And Market Forecast - 2032
... EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The Bronchopulmonary Dysplasia market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted 7MM Bronchopulmonary Dysplasia market ... Read More
-
Congenital Hyperinsulinism- Pipeline Insight, 2022
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Congenital Hyperinsulinism Understanding Congenital ... Read More
-
Acne vulgaris - Pipeline Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Acne vulgaris Understanding ... Read More
-
Migraine - Pipeline Insight, 2022
... also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Migraine: Understanding Migraine: Overview Migraine is ... Read More
-
In Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Organization Size (Large Organizations, Small and Medium Organizations); Offering (Products, Platform, Services); Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products, Others); Clinical Indication (Cardiovascular Disease, Neurodegenerative Disease, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases, Others); End User (Pharmaceutical and Biopharmaceutical Companies, Medical Technology Companies, Contract Research Organizations, Others), and Geography
... Platform, Services); Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products, Others); Clinical Indication (Cardiovascular Disease, Neurodegenerative Disease, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases, ... Read More
Research Assistance
